Document is current
Any future updates will be listed below
-
Authors
Abong’o, Bernard https://orcid.org/0000-0002-5038-604X
Gimnig, John E.
Longman, Bradley
Odongo, Tobias
Wekesa, Celestine
Webwile, Amos
Oloo, Benjamin
Nduta, Mercy
Muchoki, Margaret
Omoke, Diana
Wacira, Daniel
Opondo, Kevin
Ochomo, Eric
Munga, Stephen
Donnelly, Martin J.
Oxborough, Richard M.
-
Funding
Funding for this research was provided by:
U.S. PMI
- License Information
-
More Information
Article History
Received: 18 January 2021
Accepted: 20 May 2021
First Online: 12 June 2021
Declarations
:
: The study was approved by the Kenya Medical Research Institute/Scientific and Ethics Review Unit (KEMRI/SERU), number 2776, and by CDC through a reliance agreement with KEMRI/SERU (CDC IRB 6728). Individuals participating in outdoor trapping gave informed consent. Those conducting HLC were screened for malaria before the start of the study and treated if positive. Collectors were placed on mefloquine malaria prophylaxis (Mephaquin, Acino Pharma AG, Switzerland) 1 week before collections began, with repeat doses once every week through the collection period, until 4 weeks after collections ended. Verbal consent was sought from the household head to use CDC-LT indoor and outdoor traps in their compound. All methods were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.
